九强生物：股东ZHOU XIAOYAN拟减持不超过0.38%

Core Viewpoint - The major shareholder Zhou Xiaoyan of Jiukang Bio plans to reduce their stake in the company by selling up to 2.2142 million shares between December 3, 2025, and March 2, 2026, which represents 0.38% of the total share capital and voting shares [1] Summary by Categories - Shareholder Information - Zhou Xiaoyan holds 30.7696 million shares, accounting for 5.25% of the total share capital and 5.28% of the voting shares [1] - Reduction Plan - The planned reduction will occur through centralized bidding and/or block trading methods [1] - The maximum number of shares to be sold is 2.2142 million, which is 0.38% of the total share capital and voting shares [1]